Medtech company launches new test to protect healthcare workers
By Colin Gallant
in the Health Innovation Roundup on Aug. 19, 2026
Innovotech has launched InnovoTEST hazardous drug wipe testing kits, which are designed to help compounding pharmacies, hospitals, and cancer centres monitor hazardous drug contamination on workplace surfaces. The kits offer domestic Canadian laboratory analysis aligned with national pharmacy regulatory standards.
"By keeping sample analysis in Canada, Innovotech offers healthcare facilities a convenient domestic solution with local technical support and laboratory expertise aligned with Canadian regulatory requirements," a release reads, noting the high quality of the publicly traded company's Edmonton-based labs and the extensive expertise found there.
Innovotech has had a busy summer. It published a white paper on anti-encrustations, taking a closer look at what can be done to prevent a gnarly phenomenon that causes problems in urological care. It also reminded clients of the high quality of its standardized assay kits, used by those working in medical devices, pharmaceuticals, and related industries, as well as its testing services for those selling probiotics in natural health products.
Share